Life Sciences IP Due Diligence

A strong intellectual property portfolio is one of the most important assets for a life sciences company. Over the last year, a perfect legal and regulatory storm has been unleashed on the life sciences industry and is greatly impacting IP Due Diligence.

ACI’s 7th Annual Life Sciences IP Due Diligence Summit is devoted to providing corporate and IP counsel with the tools and critical information you need to develop winning strategies and ensure strong, valuable, and protected IP Assets that can hold up under pressure. Our esteemed speakers will provide insights on what to look for during the due diligence process, how to strategize in a shifting landscape, and how to avoid potential patent pitfalls.

ACI’s 7th Annual Summit on Life Sciences IP Due Diligence returns to Boston this December to bring you the critical information you need to develop winning strategies and ensure strong, valuable, and protected IP assets that can hold up under pressure.

Over the last year, a perfect legal and regulatory storm has been unleashed on the life sciences industry, greatly impacting IP due diligence.

From Supreme Court decisions such as Loper and Amgen, to the Federal Circuit’s rulings in Cellect and Xencor, to pending USPTO guidance on terminal disclaimers, charting a course through the choppy waters of IP due diligence is a real challenge in the life sciences arena. A strong IP portfolio, coupled with a forward-thinking due diligence strategy, will allow you to build the solid foundation you need to weather the storm and avoid disaster.

Redesign your IP Due Diligence Checklist for a tailored and bespoke approach that can withstand turbulent changes. This conference will bring you up-to-date on regulatory and policy changes, case law, and new and emerging technologies, including AI, that are having a profound effect on IP due diligence. With patent protection under the policy microscope, you’ll learn how to leverage a variety of IP protections, from traditional patents to trade secrets, to maintain valuable IP portfolios.

Get the inside scoop on red flags in diligence reviews, and avoid potential patent pitfalls — from ensuring training data ownership to avoiding the loss of a bundle of patents tied together by terminal disclaimers.

Work with your fellow practitioners on real-world problems to develop strategies and tools necessary to customize your IP due diligence approach. Learn to navigate through IP thickets, adjust for tectonic shifts in the life sciences landscape, and shore up IP value to maximize deal potential.

Hear first-hand how dealmakers and investors rely on IP due diligence at all stages. Industry stakeholders will explain what business leaders look for when making a deal and what diligence results may hinder investment.

For those newer to IP due diligence or looking to brush up on the latest tips and tricks, join us the day before the conference for our IP Due Diligence Checklist Workshop:

“The New Life Sciences IP Due Diligence Checklist: Customizing Your IP Due Diligence Checklist to Account for Legal, Regulatory, and Policy Shifts Impacting the Life Sciences.”

Register today to revamp your IP Due Diligence approach and safeguard your IP value.